Top

Published in:

01-03-2017 | Breast Oncology

Commentary on the Consensus Statement of the American Society of Breast Surgeons on Contralateral Prophylactic Mastectomy

Authors: Sharyl J. Nass, Larissa Nekhlyudov

Published in: Annals of Surgical Oncology | Issue 3/2017

Abstract

The increasing rate of contralateral prophylactic mastectomy (CPM) led the American Society of Breast Surgeons (ASBrS) to issue an evidence-based consensus statement on CPM, as well as a discussion guide that health care providers can use to facilitate shared decision making with patients considering CPM for unilateral breast cancer. This article suggests several ways to improve the discussion guide by eliciting patient values and preferences and by providing more current, detailed, and balanced information about the potential risks and benefits of CPM.

Boughey JC, Attai DJ, Chen SL, Cody HS, Dietz JR, Feldman SM, et al. Contralateral prophylactic mastectomy consensus statement from the American Society of Breast Surgeons: the data on CPM outcomes and risks. Ann Surg Oncol. 2016;23:3100–5.CrossRefPubMedPubMedCentral

Boughey JC, Attai DJ, Chen SL, Cody HS, Dietz JR, Feldman SM, et al. Contralateral prophylactic mastectomy consensus statement from the American Society of Breast Surgeons: additional considerations and a framework for shared decision making. Ann Surg Oncol. 2016;23:3106–11.CrossRefPubMedPubMedCentral

Informed Medical Decisions Foundation. Why Shared Decision Making? Retrieved 29 Sep 2016 at http://www.informedmedicaldecisions.org/shareddecisionmaking.aspx.

Whelan T, Levine M, Willan A, Gafni A, Sanders K, Mirsky D, et al. Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA. 2004;292:435–41.CrossRefPubMed

Zdenkowski N, Butow P, Tesson S, Boyle F. A systematic review of decision aids for patients making a decision about treatment for early breast cancer. Breast. 2016;26:31–45.CrossRef

Stacey, D, Légaré F, Col NF, tacey, D, Légaré F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database System Rev. 2014;(1):CD001431.

Elwyn G, O’Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333:417.CrossRefPubMedPubMedCentral

Volk RJ, Llewellyn-Thomas H, Stacey D, Elwyn G. Ten years of the International Patient Decision Aid Standards Collaboration: evolution of the core dimensions for assessing the quality of patient decision aids. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S1.CrossRef

Fagerlin A, Zikmund-Fisher BJ, Ubel PA. Helping patients decide: ten steps to better risk communication. J Natl Cancer Inst. 2011;103:1436–43.CrossRefPubMedPubMedCentral

10.

Momoh AO, Cohen WA, Kidwell KM, Hamill JB, Qi J, Pusic AL, et al. Tradeoffs associated with contralateral prophylactic mastectomy in women choosing breast reconstruction: results of a prospective multicenter cohort. Ann Surg. 2016. doi:10.1097/SLA.0000000000001840.PubMedCentral

11.

Hwang ES, Locklear TD, Rushing CN, Samsa G, Abernethy AP, Hyslop T, et al. Patient-reported outcomes after choice for contralateral prophylactic mastectomy. J Clin Oncol. 2016;34:1518–27.CrossRefPubMed

12.

Koslow S, Pharmer LA, Scott AM, Stempel M, Morrow M, Pusic AL, et al. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction. Ann Surg Oncol. 2013;20:3422–9.CrossRefPubMed

13.

National Cancer Institute. Breast Reconstruction After Mastectomy. 2016. Retrieved 31 Oct 2016 at https://www.cancer.gov/types/breast/reconstruction-fact-sheet.

14.

Cohen WA, Mundy LR, Ballard TN, Klassen A, Cano SJ, Browne J, et al. The BREAST-Q in surgical research: a review of the literature 2009–2015. Plast Reconstr Aesthet Surg. 2016;69:149–62.CrossRef

15.

Atisha DM, Rushing CN, Samsa GP, Locklear TD, Cox CE, Hwang ES, et al. A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol. 2015;22:361–9.CrossRefPubMed

16.

Howes BH, Watson DI, Xu C, Fosh B, Canepa M, Dean NR. Quality of life following total mastectomy with and without reconstruction versus breast-conserving surgery for breast cancer: a case-controlled cohort study. J Plast Reconstr Aesthet Surg. 2016;69:1184–91.CrossRefPubMed

17.

Dean NR, Crittenden TA. Five-year experience of measuring clinical effectiveness in a breast reconstruction service using the BREAST-Q patient reported outcomes measure: a cohort study. J Plast Reconstr Aesthet Surg. 2016;69:1469–77.CrossRefPubMed

18.

Yao K, Sisco M, Bedrosian I. Contralateral prophylactic mastectomy: current perspectives. Int J Womens Health. 2016;8:213–23.CrossRefPubMedPubMedCentral

19.

Margenthaler JA, Ollila DW. Breast conservation therapy versus mastectomy: shared decision-making strategies and overcoming decisional conflicts in your patients. Ann Surg Oncol. 2016;23:3133–7.CrossRefPubMed

20.

Yao K, Belkora J, Bedrosian I. Impact of an in-visit decision aid on patient knowledge about contralateral prophylactic mastectomy: a pilot study. Ann Surg Oncol. 2016;24:91–9.CrossRefPubMed

21.

Institute of Medicine; Levit LA, Balogh EP, Nass SJ, Ganz PA, eds. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Washington, DC: National Academies Press; 2013.

Title: Commentary on the Consensus Statement of the American Society of Breast Surgeons on Contralateral Prophylactic Mastectomy
Authors: Sharyl J. Nass
Larissa Nekhlyudov
Publication date: 01-03-2017
Publisher: Springer International Publishing
Published in: Annals of Surgical Oncology / Issue 3/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-016-5758-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Commentary on the Consensus Statement of the American Society of Breast Surgeons on Contralateral Prophylactic Mastectomy

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2017

Cancer Research in Low- and Middle-Income Countries: Consortiums, Implementation Science and Healthcare Delivery

Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer

When and When Not to Perform a Right Colon Resection with Mucinous Appendiceal Neoplasms

Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma

Is Routine Axillary Imaging Necessary in Clinically Node-Negative Patients Undergoing Neoadjuvant Chemotherapy?

Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy